EyePoint, Inc. (EYPT) vs Palisade Bio, Inc. (PALI)
- EyePoint, Inc. EYPT 3.00 −4.46%
- Palisade Bio, Inc. PALI 1.41 −8.44%
EyePoint, Inc. and Palisade Bio, Inc. are both Biotechnology companies. EyePoint, Inc. and Palisade Bio, Inc. are of similar size ($270.7M and $268.4M). EyePoint, Inc. has negative trailing earnings, so its P/E is not meaningful; Palisade Bio, Inc. trades at 2.2×. Palisade Bio, Inc. grew revenue faster over the last twelve months: 5,492.6% against −94.6%. Palisade Bio, Inc. has the higher net margin (−4,230.6% vs −10,998.7%) and the higher return on invested capital (0.00% vs 0.00%). Across the 16 metrics below, Palisade Bio, Inc. leads on 12 and EyePoint, Inc. on 4.
Valuation
Profitability
| Metric | EYPT | PALI | Biotechnology median |
|---|---|---|---|
| Gross margin | 41.75% | 95.63% | 65.16% |
| Operating margin | (11,369.30%) | (4,681.99%) | 0.00% |
| Net margin | (10,998.67%) | (4,230.60%) | 0.00% |
| Free cash flow margin | (9,724.68%) | (2,409.27%) | 0.00% |
| Return on equity | (148.70%) | (51.37%) | (56.36%) |
| Return on assets | (115.86%) | (47.68%) | (48.04%) |
| Return on invested capital | 0.00% | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack